Abstract
Background and Aims: Vascular Endothelial Growth Factor-A (VEGF-A -) is a biomarker of endothelial dysfunction (ED), which is involved in the development of vascular disorders and is the earliest marker of ED. Purpose was to study changes of VEGF-A level and lipids in patients with comorbid course of arterial hypertension (AH), type 2 diabetes mellitus (t2DM) and subclinical hypothyroidism (SH) for early diagnosis of vascular disorders and timely management.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
